Clinical Trials Browser

Phase 1/2 × Liver Neoplasms × Folfox protocol × Clear all

NCT06409637 2024-05-10

FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation

Phase 1/2 Not yet recruiting

Gastrointestinal

Liver Neoplasms